Emcure Pharmaceuticals (EMCURE) — Annual Report

📢 Key Event
Company dispatched letters to unregistered email shareholders with AGM and report access links.

💡 Investor Takeaway
Shareholders must update email and KYC details to receive future communications and dividend payments.

Emcure Pharmaceuticals announced that it dispatched letters to shareholders without registered email addresses, providing web links and QR codes to access the 2025-26 Annual Report and notice of its September 21, 2026 AGM via video conference, and reminded them to update KYC details and submit tax exemption forms by September 14, 2026.

📄 View Original Announcement (PDF)

📊 Stock Analysis — EMCURE ✨ Ask AI About This

About Emcure Pharmaceuticals Ltd (EMCURE)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹35,011.16 Cr P/E: 34.6 ROE: 22.9% ROCE: 29.7% Div Yield: 0.20%

View full EMCURE stock details →

📡 Get AI alerts when EMCURE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track EMCURE — Free

💡 Ask AI about this filing

"What is the expected dividend payout ratio for FY 2025-26?" "How does Emcure's capex plan compare to peers?" "What is the projected revenue growth for FY 2026-27?"

Ask AI Free →

📊 More EMCURE filings

See all EMCURE filings →

🔥 Also filed on 1 September 2026

WHBRADY W H Brady & Co Ltd Annual Report 544542 Justo Realfintech Ltd Annual Report 544083 Shree Marutinandan Tubes Ltd Annual Report SHERVANI Shervani Industrial Syndicate Ltd Corporate Action CORDSCABLE Cords Cable Industries Ltd Annual Report SUDARSCHEM Sudarshan Chemical Industries Ltd Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when EMCURE files new disclosures

Track EMCURE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track EMCURE — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd